Q4 2020 Holdings
Filed 2021-02-16 | 266 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $278.0M | 945,348 | 18.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $208.4M | 1,603,500 | 13.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $186.1M | 2,191,503 | 12.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $182.0M | 4,201,002 | 12.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $138.1M | 564,000 | 9.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $79.4M | 2,209,859 | 5.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $71.1M | 1,185,047 | 4.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $60.3M | 112,768 | 4.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $45.0M | 1,403,000 | 3.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $40.2M | 375,500 | 2.7% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $37.5M | 64,405 | 2.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $35.7M | 143,018 | 2.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $32.4M | 396,821 | 2.1% |
| Atricure Inc(ATRC) | COM | 04963C209 | $31.0M | 556,374 | 2.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $27.7M | 107,100 | 1.8% |
| Caredx Inc(CDNA) | COM | 14167L103 | $24.9M | 343,983 | 1.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $14.4M | 512,216 | 1.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $2.6M | 149,000 | 0.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.6M | 15,500 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.4M | 44,900 | 0.2% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $2.3M | 83,500 | 0.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.5M | 18,000 | 0.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.3M | 51,000 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $511.7K | 9,050,092 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $451.0K | 2,059 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $325.6K | 3,396,651 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $307.9K | 2,946,913 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $292.8K | 1,238,985 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $261.7K | 3,008,700 | 0.0% |
| Blackbaud Inc(BLKB) | COM | 09227Q100 | $236.0K | 4,107 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $217.6K | 1,393,028 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $191.6K | 2,107,500 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $172.8K | 4,045,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $160.4K | 196,020 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $152.9K | 1,396,873 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $139.3K | 909,684 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $135.6K | 1,567,504 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $135.0K | 5,904,517 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $134.5K | 7,531,414 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $133.6K | 5,138,451 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $132.7K | 4,804,039 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $118.6K | 533,794 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $116.4K | 3,659,919 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $111.9K | 1,804,472 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $111.0K | 2,286,651 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $107.8K | 335,793 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $107.3K | 306,045 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $97.3K | 237,067 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $86.3K | 337,468 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $86.0K | 413,208 | 0.0% |